PAREXEL International has introduced PAREXEL MyTrials platform to provide support for the drug development process.
Perceptive Informatics, PAREXEL's technology subsidiary, developed the fully-integrated eClinical platform.
PAREXEL chief operating officer Mark Goldberg said with the availability of PAREXEL MyTrials, users will have a single place to access a comprehensive suite of applications, tools, metrics and reports through full data integration and application convergence.
"They can expect to realize greater efficiency and conduct more effective trials by harnessing the power of this innovative platform technology and leveraging our integrated product suite, regardless the size, scope or the numbers of trials," Goldberg added.
PAREXEL MyTrials features convergence to move between applications, scalability to handle single or multiple studies, reporting to view health and progress of trials and collaboration across the entire study community.
The single sign-on allows access to multiple technologies, trials and programs from a single place with a single set of credentials for efficient workflows and task continuity, according to the company.
The platform offers access to a suite of integrated applications, data and information associated with all types of trials and programs, including DataLabs EDC, DataLabs Designer, ClinPhone RTSM, IMPACT CTMS, ePRO, Medical Imaging, eClinical Metrics reporting, Site-Sponsor collaboration.